Enertor

Short Summary
Transform sports recovery and performance with Enertor’s PX1® technology, which reduces impact by 51%. Our proprietary insole technology was clinically proven in British Army trials to reduce lower limb injury risk by 69%. Now profitable and scaling.

Highlights
Profitable after 5 consecutive years of growth
Patent-backed technology platform with multiple filings
88% gross margins enabling strong operating leverage
Proven ability to launch and sell out new products rapidly
Scaling internationally across UK, US and Denmark

Link: https://www.angelinvestmentnetwork.com.ng/business-proposals/enertor-15-928363